Espumizan capsules №50

$30.00

Manufacturer: Germany

Purpose: Simethicone reduces gas bubbles in the stomach and intestines.

SKU: MED58256 Category:

Description

Espumizan Capsules №50

Ingredients

Espumizan capsules №50 contain Simethicone as the active ingredient.

Dosage

Adults: Take 1-2 capsules up to 4 times a day after meals and at bedtime. Children: Consult a healthcare professional for appropriate dosage.

Indications

Espumizan capsules №50 are indicated for the relief of symptoms associated with excess gas in the gastrointestinal tract, such as bloating and flatulence.

Contraindications

Do not use Espumizan capsules №50 if you are allergic to any of the ingredients. Consult a doctor before use if you are pregnant, breastfeeding, or have any underlying medical conditions.

Directions

Swallow the capsules whole with a glass of water. Do not crush or chew the capsules. Follow the recommended dosage instructions for best results.

Scientific Evidence

Studies have shown that Simethicone, the active ingredient in Espumizan capsules №50, works by breaking down gas bubbles in the gastrointestinal tract, providing relief from gas-related symptoms. Research published in the Journal of Pediatric Gastroenterology and Nutrition demonstrated the efficacy of Simethicone in reducing gas-related discomfort in infants and children.

Additional Information

It is important to note that Espumizan capsules №50 are not intended for long-term use. If symptoms persist, consult a healthcare professional. Store the capsules in a cool, dry place away from direct sunlight.

Pharmacological Effects: Simethicone acts as an anti-foaming agent in the gastrointestinal tract, reducing the surface tension of gas bubbles, allowing them to combine and be expelled more easily. This helps alleviate symptoms of gas and bloating.

Clinical Trials: In a randomized controlled trial published in the American Journal of Gastroenterology, patients with irritable bowel syndrome who took Simethicone experienced a significant reduction in bloating and abdominal discomfort compared to a placebo group.